Healthways Inc. (HWAY) Earns Outperform Rating from Barrington Research
Healthways Inc. (NASDAQ:HWAY)‘s stock had its “outperform” rating reissued by analysts at Barrington Research in a report released on Thursday.
A number of other analysts have also recently issued reports on HWAY. Jefferies Group lifted their price objective on Healthways from $13.00 to $18.50 and gave the company a “hold” rating in a research report on Thursday, August 4th. Zacks Investment Research raised Healthways from a “hold” rating to a “buy” rating and set a $20.00 price objective for the company in a research report on Monday, August 8th. FBR & Co lifted their price objective on Healthways from $16.00 to $21.00 and gave the company an “outperform” rating in a research report on Wednesday, August 10th. Piper Jaffray Cos. lifted their price objective on Healthways from $15.00 to $25.50 and gave the company an “overweight” rating in a research report on Wednesday, August 10th. Finally, Oppenheimer Holdings Inc. raised Healthways to an “outperform” rating and set a $27.00 price target for the company in a research report on Sunday, August 14th. Two equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Healthways currently has an average rating of “Buy” and an average target price of $24.21.
Healthways (NASDAQ:HWAY) traded up 0.04% during midday trading on Thursday, hitting $25.01. The stock had a trading volume of 128,581 shares. Healthways has a 12-month low of $9.18 and a 12-month high of $27.30. The stock’s market cap is $918.82 million. The company’s 50-day moving average price is $25.35 and its 200 day moving average price is $16.32.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/13/healthways-inc-hway-earns-outperform-rating-from-barrington-research.html
Healthways (NASDAQ:HWAY) last issued its quarterly earnings results on Tuesday, August 9th. The company reported $0.54 earnings per share for the quarter, beating analysts’ consensus estimates of $0.01 by $0.53. The business had revenue of $125 million for the quarter, compared to the consensus estimate of $186.88 million. Healthways had a positive return on equity of 8.83% and a negative net margin of 31.32%. Healthways’s revenue for the quarter was up 10.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.11 earnings per share. On average, equities research analysts predict that Healthways will post $2.11 earnings per share for the current fiscal year.
In related news, Director Mary Jane England sold 3,816 shares of the business’s stock in a transaction dated Friday, August 26th. The stock was sold at an average price of $24.78, for a total transaction of $94,560.48. Following the transaction, the director now directly owns 39,068 shares in the company, valued at $968,105.04. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 14.01% of the company’s stock.
Institutional investors have recently modified their holdings of the stock. Dimensional Fund Advisors LP raised its position in shares of Healthways by 8.2% in the second quarter. Dimensional Fund Advisors LP now owns 3,058,854 shares of the company’s stock valued at $35,330,000 after buying an additional 230,768 shares in the last quarter. Vanguard Group Inc. raised its position in shares of Healthways by 6.0% in the second quarter. Vanguard Group Inc. now owns 2,622,631 shares of the company’s stock valued at $30,292,000 after buying an additional 148,879 shares in the last quarter. BlackRock Fund Advisors raised its position in shares of Healthways by 4.0% in the second quarter. BlackRock Fund Advisors now owns 2,341,455 shares of the company’s stock valued at $27,044,000 after buying an additional 90,444 shares in the last quarter. Royce & Associates LP raised its position in shares of Healthways by 1.1% in the second quarter. Royce & Associates LP now owns 913,204 shares of the company’s stock valued at $10,548,000 after buying an additional 10,000 shares in the last quarter. Finally, Rutabaga Capital Management LLC MA raised its position in shares of Healthways by 359.7% in the second quarter. Rutabaga Capital Management LLC MA now owns 866,087 shares of the company’s stock valued at $10,003,000 after buying an additional 677,677 shares in the last quarter. Hedge funds and other institutional investors own 92.52% of the company’s stock.
Healthways, Inc (Healthways) provides network delivered solutions and population health management services that are designed to help people manage their wellbeing, thereby managing their health and productivity, and their health-related costs. The Company operates in the domestic and international segments, which are collectively known as the well-being improvement services segment.
Receive News & Ratings for Healthways Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthways Inc. and related companies with MarketBeat.com's FREE daily email newsletter.